Company Monitoring Page for Gilead-Sciences

latest headlines for company on cafepharma

Can Cambrex Keep Profits Healthy On Gilead Pact?
Investors.com
Sat, 06/27/15 - 11:38 am
Tags:
Cambrex, Gilead Sciences, drug manufacturing
Gilead Is Set For Another Strong Quarter
Seeking Alpha
Fri, 06/26/15 - 08:07 pm
Tags:
Gilead Sciences
China Rejects Gilead's Sovaldi Patent Application
Yahoo/Benzinga
Sun, 06/21/15 - 01:35 pm
Tags:
China, Gilead Sciences, Sovaldi, patents, hepatitis C
Gilead Sciences: New Harvoni Prescriptions Decelerate
Barron's
Fri, 06/19/15 - 05:14 pm
Tags:
Gilead Sciences, Harvoni, hepatitis C, prescription data
Despite insider sale, Receptos stock surges on takeover rumors
BioPharma Dive
Thu, 06/18/15 - 11:14 am
Tags:
Receptos, M&A, AstraZeneca, Teva Pharmaceutical, Gilead Sciences, MS, multiple sclerosis
For Pharma, the Hollywood Model of Buying Pipeline Hits is not a Panacea
WSJ Pharmalot
Tue, 06/16/15 - 12:17 pm
Tags:
JNJ, Gilead Sciences, hepatitis C, Pharmacyclics
No One Knows Why Gilead is Flying
Barron's
Fri, 06/12/15 - 09:30 am
Tags:
Gilead Sciences
Gilead CEO's $21 Million Stock Sale
Barron's
Mon, 06/8/15 - 10:05 pm
Tags:
Gilead Sciences, Pharma CEOs, John C. Martin
Gilead Sciences: What Game Theory Teaches Us About Hepatitis C
Barron's
Fri, 06/5/15 - 11:29 am
Tags:
Gilead Sciences, hepatitis C
Gilead Sciences Will Do Some Deals, Surprise to the Upside
Barron's
Wed, 06/3/15 - 12:31 pm
Tags:
Gilead Sciences
Merck Takes Aim at Gilead. Should You Worry?
Investopedia
Sat, 05/30/15 - 12:27 pm
Tags:
Merck, Gilead Sciences, Harvoni, Sovaldi, hepatitis C, grazoprevir/elbasvir
Gilead on R&D hiring spree
BioPharma Dive
Fri, 05/29/15 - 10:42 am
Tags:
Gilead Sciences, R&D, hirings
Will Gilead's Hepatitis C Dominance Collapse?
Investopedia
Fri, 05/29/15 - 10:21 am
Tags:
Gilead Sciences, hepatitis C, Harvoni, Sovaldi, JNJ
Gilead cuts ribbon on innovative new laboratory, announces additional $100m investment in Edmonton
Yahoo
Thu, 05/28/15 - 09:14 am
Tags:
Gilead Sciences
GlobeImmune, Gilead Hep B drug fails in mid-stage study
Yahoo/Reuters
Wed, 05/27/15 - 09:53 am
Tags:
GlobeImmune, Gilead Sciences, hepatitis B, GS-4774
The Gilead effect: PCSK9 rivals Amgen, Sanofi/Regeneron prep for a price war
Fierce Biotech
Tue, 05/26/15 - 04:52 pm
Tags:
Gilead Sciences, PCSK9 inhibitors, Amgen, Sanofi, Regeneron, drug pricing, Repatha, Praluent
Consumers Sue Anthem for Denying Coverage for a Gilead Hepatitis C Drug
WSJ Pharmalot
Tue, 05/26/15 - 10:55 am
Tags:
Gilead Sciences, hepatitis C, Anthem, Harvoni
The Most Loved Biotechs of Big Hedge Funds
24/7 Wall St
Sat, 05/23/15 - 11:41 am
Tags:
biotech, Pharmacyclics, Gilead Sciences, Regeneron, Celgene, Amgen
Will This Drug Beat Gilead to Market in NASH?
Investopedia
Sat, 05/23/15 - 11:35 am
Tags:
Gilead Sciences, NASH, OCA, Intercept Pharma
Gilead Sciences: Hep-C Prescriptions Continue to Fall
Barron's
Fri, 05/22/15 - 12:00 pm
Tags:
Gilead Sciences, hepatitis C, Harvoni, Sovaldi

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.